Clinical trial

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

NCT01307488

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-09-01

PhasePHASE4

Study timeline

Study start (unknown)2011-09-01Date precision: month

Registry last updated2015-05-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionunresolved

Interventions

Ritonavir boosted Atazanavir + LamivudineDRUG

Ritonavir boosted Atazanavir + 2 NRTIsDRUG

Sponsors & collaborators

Fundacion SEIMC-GESIDAlead sponsor

Bristol-Myers Squibbcollaborator

Mapped research locations

MadridSpain4 BarcelonaSpain2 MadridMadrid, Spain2 GranadaSpain2 ValenciaSpain1 MálagaSpain1 A CoruñaSpain1 AlicanteSpain1 CórdobaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01307488 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.